Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial.
Molina-Morant D, Fernández ML, Bosch-Nicolau P, Sulleiro E, Bangher M, Salvador F, Sanchez-Montalva A, Ribeiro ALP, de Paula AMB, Eloi S, Correa-Oliveira R, Villar JC, Sosa-Estani S, Molina I. Molina-Morant D, et al. Among authors: sosa estani s. Trials. 2023 Nov 14;24(1):726. doi: 10.1186/s13063-023-07659-5. Trials. 2023. PMID: 37964376 Free PMC article. No abstract available.
Treatments for dengue: a Global Dengue Alliance to address unmet needs.
Dengue Alliance. Electronic address: gnmalavige@dndi.org; Dengue Alliance. Dengue Alliance. Electronic address: gnmalavige@dndi.org, et al. Lancet Glob Health. 2023 Nov;11(11):e1680-e1681. doi: 10.1016/S2214-109X(23)00362-5. Epub 2023 Aug 31. Lancet Glob Health. 2023. PMID: 37660714 Free article. No abstract available.
Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial.
Bosch-Nicolau P, Fernández ML, Sulleiro E, Villar JC, Perez-Molina JA, Correa-Oliveira R, Sosa-Estani S, Sánchez-Montalvá A, Del Carmen Bangher M, Moreira OC, Salvador F, Mota Ferreira A, Eloi-Santos SM, Serre-Delcor N, Ramírez JC, Silgado A, Oliveira I, Martín O, Aznar ML, Ribeiro ALP, Almeida PEC, Chamorro-Tojeiro S, Espinosa-Pereiro J, de Paula AMB, Váquiro-Herrera E, Tur C, Molina I; MULTIBENZ Study Group. Bosch-Nicolau P, et al. Among authors: sosa estani s. Lancet Infect Dis. 2024 Apr;24(4):386-394. doi: 10.1016/S1473-3099(23)00629-1. Epub 2024 Jan 11. Lancet Infect Dis. 2024. PMID: 38218195 Clinical Trial.
Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial.
Pinazo MJ, Forsyth C, Losada I, Esteban ET, García-Rodríguez M, Villegas ML, Molina I, Crespillo-Andújar C, Gállego M, Ballart C, Ramirez JC, Aden T, Hoerauf A, Pfarr K, Vaillant M, Marques T, Fernandes J, Blum B, Ribeiro I, Sosa-Estani S, Barreira F, Gascón J; FEXI-12 Study Team. Pinazo MJ, et al. Among authors: sosa estani s. Lancet Infect Dis. 2024 Apr;24(4):395-403. doi: 10.1016/S1473-3099(23)00651-5. Epub 2024 Jan 11. Lancet Infect Dis. 2024. PMID: 38218194 Clinical Trial.
Direct evidence gap on fixed versus adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: Systematic review and individual patient data meta-analysis.
Ciapponi A, Barreira F, Perelli L, Bardach A, Gascón J, Molina I, Morillo C, Prado N, Riarte A, Torrico F, Villar JC, Reidel S, Gibbons L, Sosa-Estani S. Ciapponi A, et al. Among authors: sosa estani s. Trop Med Int Health. 2023 Jan;28(1):2-16. doi: 10.1111/tmi.13831. Epub 2022 Dec 1. Trop Med Int Health. 2023. PMID: 36420767 Free article. Review.
Human Trypanosoma cruzi chronic infection leads to individual level steady-state parasitemia: Implications for drug-trial optimization in Chagas disease.
De Salazar PM, Sosa-Estani S, Salvador F, Sulleiro E, Sánchez-Montalvá A, Ribeiro I, Molina I, Buckee CO. De Salazar PM, et al. Among authors: sosa estani s. PLoS Negl Trop Dis. 2022 Nov 21;16(11):e0010828. doi: 10.1371/journal.pntd.0010828. eCollection 2022 Nov. PLoS Negl Trop Dis. 2022. PMID: 36409773 Free PMC article.
Critical analysis of Chagas disease treatment in different countries.
Mendes FSNS, Perez-Molina JA, Angheben A, Meymandi SK, Sosa-Estani S, Molina I. Mendes FSNS, et al. Among authors: sosa estani s. Mem Inst Oswaldo Cruz. 2022 Jul 8;117:e210034. doi: 10.1590/0074-02760210034. eCollection 2022. Mem Inst Oswaldo Cruz. 2022. PMID: 35830002 Free PMC article. Review.
The translational challenge in Chagas disease drug development.
Kratz JM, Gonçalves KR, Romera LM, Moraes CB, Bittencourt-Cunha P, Schenkman S, Chatelain E, Sosa-Estani S. Kratz JM, et al. Among authors: sosa estani s. Mem Inst Oswaldo Cruz. 2022 May 23;117:e200501. doi: 10.1590/0074-02760200501. eCollection 2022. Mem Inst Oswaldo Cruz. 2022. PMID: 35613156 Free PMC article. Review.
108 results